gold has been researched along with Alzheimer Disease in 162 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.85) | 18.7374 |
| 1990's | 2 (1.23) | 18.2507 |
| 2000's | 3 (1.85) | 29.6817 |
| 2010's | 73 (45.06) | 24.3611 |
| 2020's | 81 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gatasheh, MK; Saranya, V; Shankar, R; Zehra, S | 1 |
| Ma, F; Wang, Q; Xu, Q; Zhang, CY | 1 |
| Chen, CC; Han, HF; Jiang, HS; Qian, K; Tan, HY; Tsai, PJ; Wu, HC; Wu, YC; Xu, W; Yen, HC | 1 |
| Gao, Y; Song, W; Yan, J; Zhang, J; Zhang, X | 1 |
| Fu, Y; Sun, H; Wang, J; Xie, Y; Yu, L | 1 |
| Bai, Z; Gao, F; Ge, K; Geng, D; Liu, M; Liu, Z; Mu, Y | 1 |
| Chenaghlou, S; Jalili, R; Khalilzadeh, B; Khataee, A; Rashidi, MR | 1 |
| Furkan, M; Khan, MS; Khan, RH; Kumar, A; Nami, SAA; Parveen, M; Rehman, R | 1 |
| Correa-Duarte, MA; Eduarda Schneider, M; Guillade, L; Moreira, FTC | 1 |
| Dube, T; Kour, A; Kumar, A; Panda, JJ | 1 |
| Ji, J; Li, S; Pan, G; Wu, A | 1 |
| Dong, X; Liu, W; Sun, Y; Zhang, H | 1 |
| Davies, HA; Lévy, R; Madine, J; Sharkey, J; Soliman, MG | 1 |
| Aldunate, R; Álvarez, A; Araya, E; Cabrera, P; Campos, A; Jara-Guajardo, P; Kogan, MJ; Minniti, AN; Morales-Zavala, F; Oyarzún, MP; Parra-Muñoz, N; Soler, M | 1 |
| Huang, W; Sun, T; Yang, T; Yu, Y; Zhang, J | 1 |
| Chiang, MC; Nicol, CJB | 1 |
| Li, M; Liu, Q; Liu, X; Liu, Y; Xu, T | 1 |
| Dong, J; Fei, R; Ge, Q; Lu, Y; Meng, D; Wan, Y; Wu, X; Zhan, Y; Zhao, X | 1 |
| Liu, A; Sheng, X; Xie, H; Zhong, M; Zhou, B; Zhou, S | 1 |
| Chen, JM; Chen, KL; Jeng, CC; Kumar, P; Lin, CW; Lin, YJ; Tsai, PH; Tsao, HM; Wang, LM; Wu, CH | 1 |
| Fernando, NK; Fleck, RA; Kiryushko, D; Klosowski, M; Machado, P; Morfill, C; Pankratova, S; Pinna, A; Porter, AE; Regoutz, A; Talamona, F; Wilkinson, RJ; Xie, F | 1 |
| Guan, Y; Guo, X; Li, Z; Qin, J; Tang, J; Wang, D; Zhang, M | 1 |
| Faridbod, F; Ghanian, MH; Kazemi Ashtiani, M; Shahpasand, K; Shekari, F; Shiravandi, A; Tofigh, N; Yari, F | 1 |
| Bhattacharya, S | 1 |
| Amato, J; Cinti, S; Fuso, A; Lucarelli, M; Marzano, S; Miglione, A; Pagano, B; Raia, T; Raucci, A | 1 |
| Khan, R; Ranjan, P | 1 |
| Datta, LP; Govindaraju, T; Moorthy, H; Samanta, S | 1 |
| Feng, Y; Ji, D; Li, X; Peng, Q; Shen, Y; Tian, J; Xiao, Y | 1 |
| Gao, Y; Shen, X; Song, X; Wang, G; Wang, N; Wo, X | 1 |
| Andrikopoulos, N; Davis, TP; Ding, F; Ke, PC; Li, Y; Nandakumar, A; Quinn, JF; Saikia, N | 1 |
| Gao, X; Han, J; Huang, H; Li, F; Liu, Y; Qian, C; Shi, F; Stewart, C; Xu, L; Xu, Y; Yang, S; Yu, Y | 1 |
| Gómez-Gómez, B; León-González, ME; Madrid, Y; Romero-Sánchez, I; Rosales-Conrado, N; Vicente-Zurdo, D | 1 |
| Castaño, O; Kogan, MJ; Lagunas, A; López-Canosa, A; Mir, M; Moralez-Zavala, F; Palma-Florez, S; Samitier, J | 1 |
| Chen, Y; Jia, Z; Liu, J; Yang, L; Yuan, X | 1 |
| Chai, K; Hu, X; Hu, Y; Shi, S; Tu, Y; Wu, J; Yao, T | 1 |
| Dhushyandhun, ME; Elangovan, S; Gulia, KK; Jayasree, RS; Rekha, CR; Resmi, AN; Shenoy, SJ | 1 |
| Chen, Z; Feng, M; Hua, J; Luo, C; Shi, Z; Sun, J; Wang, L; Wang, M; Xu, C; Zhang, X | 1 |
| Chotkowski, M; Kaczyńska, K; Maurin, JK; Mazur, M; Mojzych, I; Wiktorska, K; Wojciechowski, P; Zając, D; Zawadzka, A | 1 |
| Deng, C; Shi, F; Sun, N; Yan, Y; Zhang, H | 1 |
| Cominetti, MR; de Oliveira, TR; Faria, RC; Leite, OD; Manzine, PR | 1 |
| Aili, M; Luo, F; Zhan, J; Zheng, H; Zhou, K | 1 |
| Huang, Z; Li, M; Liu, Y; Zeng, Y; Zhang, L | 1 |
| Angnes, L; Bacil, RP; Buoro, RM; Negahdary, M; Santos, BG | 1 |
| Bagnoli, S; Bessi, V; Credi, C; Dallari, C; Lenci, E; Nacmias, B; Pavone, FS; Trabocchi, A | 1 |
| Abolhasan, R; Chakari-Khiavi, F; Kamrani, A; Khalilzadeh, B; Mirzaie, A; Pourakbari, R; Rashidi, MR; Shahpasand, K; Yousefi, H; Yousefi, M | 1 |
| Kong, S; Li, H; Tan, R; Tu, Y; Wang, Y; Wen, X | 1 |
| Guo, X; Kuang, H; Li, C; Sun, M; Xu, C; Xu, J; Xu, L; Zhang, J | 1 |
| Bhuiyan, NH; Jin, GJ; Park, M; Rahman, MM; Shim, JS; Uddin, MJ | 1 |
| Chen, M; Li, M; Liu, X; Su, X; Xie, Y | 1 |
| Davis, TP; Ding, F; Faridi, A; Javed, I; Kakinen, A; Ke, PC; Lin, S; Parish, CL; Peng, G; Xing, Y; Yu, T; Zhao, M | 1 |
| Chang, HM; Cheng, CH; Hong, CT; Hsiao, IT; Hu, CJ; Lin, KJ; Liu, CH; Liu, YC; Wu, D; Yang, CP | 1 |
| Chinnadayyala, SR; Cho, S; Ngoc Le, HT; Park, J | 1 |
| Arruda, R; Canteiro, PB; da Silva, S; de Bem Silveira, G; Dos Santos Tramontin, N; Mendes, C; Muller, AP; Silveira, PCL; Ugioni, KS | 1 |
| Brazaca, LC; Martín, A; Moreto, JR; Tehrani, F; Wang, J; Zucolotto, V | 1 |
| Amor-Gutiérrez, O; Arce-Varas, N; Costa-García, A; Costa-Rama, E; Fernández-Sánchez, MT; Martínez-Rodríguez, C; Novelli, A | 1 |
| Miao, YB; Ren, HX; Zhang, Y | 1 |
| Artyushenko, V; Bibikova, O; Centi, S; Cicchi, R; Credi, C; Dallari, C; Pavone, FS; Pini, R; Ratto, F; Tiribilli, B | 1 |
| Ding, S; Gu, H; Liu, Q; Shi, G; Xu, Y; Zhu, A | 1 |
| Andreozzi, P; Cassina, V; Corti, R; Cox, A; Dal Magro, R; Mantegazza, F; Marrano, CA; Missana, N; Nardo, L; Re, F; Salerno, D; Silva, PJ; Stellacci, F | 1 |
| Choi, I; Danish Rizvi, SM; Farhana, A; Hussain, T; Nazam, N; Shaikh, S | 1 |
| Ait-Bouziad, N; Alexander-Katz, A; Cendrowska, U; Chiki, A; Fändrich, M; Guven, ZP; Kumar, ST; Lashuel, HA; Menziani, MC; Müller, M; Radamaker, L; Silva, PJ; Stellacci, F; Tavanti, F; Vieweg, S | 1 |
| Cho, S; Jung, YS; Kim, M; Park, HJ | 1 |
| Chen, SJ; Cheng, YC; Chiang, MC; Huang, RN; Lin, CH; Nicol, CJB; Yen, C | 1 |
| Amor-Gutiérrez, O; Costa-García, A; de la Escosura-Muñiz, A; Fernández-Sánchez, MT; Iglesias-Mayor, A; Novelli, A | 1 |
| Chen, G; Dong, H; Gao, F; Ge, K; Geng, D; Gong, L; Li, N; Machuki, JO; Pan, W; Yin, Y; Yu, Y | 1 |
| Barderas, R; Calero, M; Campuzano, S; Gamella, M; Lobo, AO; Montero-Calle, A; Pedrero, M; Pingarrón, JM; Razzino, CA; Serafín, V; Yáñez-Sedeño, P | 1 |
| Banchelli, M; D'Andrea, C; De Angelis, M; Eravuchira, P; Gannot, I; Matteini, P | 1 |
| Figueroa-Miranda, G; Mayer, D; Offenhäusser, A; Willbold, D; Wu, C; Zhang, Y | 1 |
| Sezgintürk, MK; Sonuç Karaboga, MN | 1 |
| Ai, J; Cao, Q; Hou, K; Huang, Q; Li, B; Li, K; Liu, S; Lv, J; Shi, X; Tang, Z; Wan, K; Wang, D; Wang, H; Zhao, J | 1 |
| Ebrahimi, A; Mehrabani, M; Ravan, H | 1 |
| Chen, Z; Cheng, X; Ding, T; Liu, J; Niu, Y; Tang, B; Tong, L; Yang, Y; Zhang, G | 1 |
| Gao, G; He, M; Li, J; Sun, T; Tang, X; Yu, M | 1 |
| Li, H; Tan, R; Tu, Y; Wang, Y; Yin, L | 1 |
| Guo, Y; Liu, R; Xu, L; Zhang, D; Zhang, J; Zhang, Z; Zhu, J | 1 |
| Feng, L; Gao, X; Han, Y; Li, H; Luo, S; Pan, H; Xiong, J | 1 |
| Gajdová, Ž; Gallo, J; Kolář, M; Kvítek, L; Panáček, A; Prucek, R; Večeřová, R | 1 |
| Anbu, P; Duan, C; Gopinath, SCB; Jiang, C; Lakshmipriya, T; Li, J; Li, R; Li, X; Qiu, Z; Shen, Q; Sun, X; Yao, L | 1 |
| Chen, Q; Gu, X; Li, L; Lv, L; Wang, X; Xu, M; Yu, B | 1 |
| Acosta, G; Albericio, F; Alvarez R, A; Araya, E; Chamorro, D; Chandia-Cristi, A; Giralt, E; Jara-Guajardo, P; Kogan, MJ; Morales-Zavala, F; Pismante, P; Riveros, AL; Salgado, N; Sánchez-Navarro, M; Vasquez, R | 1 |
| Cho, S; Phan, LM | 1 |
| Chakrabarti, P; Chatterjee, T; Das, G; Ghosh, S | 1 |
| Chen, C; Hao, C; Kuang, H; Ma, W; Qu, A; Wang, G; Xu, C; Xu, J; Xu, L | 1 |
| Chen, HZ; Cheng, Q; Liu, JJ; Liu, Y; Liu, ZK; Ni, WW; Song, M; Wang, SS; Wang, YX | 1 |
| Bharadwaj, S; Bharti, K; Chaudhary, RK; Dwivedi, VD; Kaushik, AC; Kumar, A; Kumar, P; Kumar, S; Mishra, SK | 1 |
| Brandolfi, JA; de Bem Silveira, G; de Souza, CT; de Souza, DL; Ferreira, GK; Muller, AP; Paula, MMS; Pires, AJ; Silveira, PCL | 1 |
| Aldunate, R; Álvarez, AR; Araya, E; Arriagada, H; Giralt, E; Hassan, N; Kogan, MJ; Minniti, AN; Morales-Zavala, F; Muñoz, LL; Riveros, A; Rodriguez, K; Rojas-Silva, X; Sanchez-Navarro, M; Vasquez, R; Velasco, C | 1 |
| Amin, FU; Kim, MJ; Kim, MO; Rehman, SU | 1 |
| Aghaie, A; Aghamollaii, V; Aghaverdi, H; Alekhamis, Z; Atyabi, F; Azhdarzadeh, M; Bargahi, A; Derakhshankhah, H; Ghasemi, F; Hajipour, MJ; Hashemi, E; Linne, U; Lotfabadi, A; Mahmoudi, M; Mashhadi, MM; Nabipour, I; Raoufi, M; Sheibani, S; Tafakhori, A; Vali, H | 1 |
| Guan, Y; Li, M; Qu, X; Ren, J; Zhao, A | 1 |
| Kim, H; Kim, S; Lee, JU; Sim, SJ; Song, S | 1 |
| Catt, M; Garyfallou, GZ; Ketebu, O; Mukaetova-Ladinska, EB; Şahin, S; Yu, EH | 1 |
| Cheng, XR; Endo, T; Kerman, K; Su, H | 1 |
| Deng, C; Deng, H; Deng, W; Jiao, B; Jin, Y; Lei, C; Liu, H; Shen, L; Tu, Q; Xiang, J; Xiang, L; Xie, Y; Zhang, M | 1 |
| Gui, J; Sun, L; Wang, X; Weng, J; Zhong, Y; Zhuang, X | 1 |
| Ghasemi, F; Hormozi-Nezhad, MR; Mahmoudi, M | 1 |
| Lee, D; Lee, G; Yoon, DS | 1 |
| Li, H; Liu, Y; Luo, Y; Song, M; Sun, Y; Zhu, Y | 1 |
| Cheng, J; Guo, Z; Jaffrezic-Renault, N; Mei, Y; Shui, B; Tao, D | 1 |
| Abel, B; Gladytz, A; John, T; Kubeil, C; Martin, LL; Risselada, HJ | 1 |
| Cong, L; Du, Y; Han, X; Li, W; Liu, Z; Man, Z; Tang, S; Wang, X; Wang, Y; Xu, S; Zhang, Q | 1 |
| Lu, H; Wang, J; Wang, N; Wang, Z; Wu, L; Yi, X | 1 |
| Baatsen, P; Corthout, N; Gounko, NV; Munck, S; Pavie, B; Rybakin, V; Vandael, D; Vernaillen, F; Vints, K | 1 |
| Ferré-Borrull, J; Kapruwan, P; Marsal, LF; Tabrizi, MA | 1 |
| Angel, A; Ashery, U; Betzer, O; Brenstein, S; Offen, D; Perets, N; Popovtzer, R; Sadan, T; Shapira, R | 1 |
| Heli, H; Negahdary, M | 1 |
| Aminyavari, S; Ghasemi, F; Gholami, M; Hajipour, MJ; Imani, M; Kebriaeezadeh, A; Khodagholi, F; Mahmoudi, M; Sabzevari, O; Sanati, M; Sharifzadeh, M | 1 |
| Abou-Taleb, HA; Kharshoum, RM; Naguib, DM; Salem, HF | 1 |
| Bai, S; Gao, R; Jiang, X; Kong, W; Kuai, Z; Li, W; Liu, D; Liu, J; Liu, X; Shan, Y; Shi, Y | 1 |
| Chen, L; Gong, Y; Liu, J; Liu, Y; Yin, T; Yuan, G; Zhou, H | 1 |
| Cheng, J; Gu, Y; Guo, Z; Jaffrezic-Renault, N; Shui, B; Song, S; Tao, D; Zhang, W | 1 |
| Huang, J; Liu, S; Song, X; Wang, H; Wang, J; Wang, Y; Yu, J; Zhang, X | 1 |
| Cho, M; Lee, Y; Qin, J | 1 |
| Liu, L; Ma, F; Xia, N; Yang, S; Zhang, L; Zhao, F | 1 |
| Han, H; Wang, J; Yi, X; Zhang, Y; Zhou, F | 1 |
| Chang, YW; Jose, J; Kim, E; Kim, HJ; Oh, J; Pyun, JC; Yoo, G; Yoo, KH | 1 |
| Chang, CW; Chou, HH; Hsieh, S | 1 |
| de Klerk, N; Fritschi, L; Musk, AW; Peters, S; Reid, A | 1 |
| Lee, LP; Lee, SS | 1 |
| Bartos, A; Dráber, P; Dráberová, E; Rípová, D; Stegurová, L | 1 |
| Neumann, B; Scheller, F; Wollenberger, U; Yarman, A | 1 |
| Kim, WM; Lee, KS; Lee, YK; Sohn, YS | 1 |
| de la Escosura-Muñiz, A; Horák, D; Merkoçi, A; Plichta, Z | 1 |
| Dong, K; Gao, N; Qu, X; Ren, J; Sun, H | 1 |
| Li, C; Nie, D; Shi, G; Sun, X; Tang, D; Yin, X; Yu, Y; Zhang, L | 1 |
| Dong, H; Liu, L; Xu, M; Zhou, Y | 1 |
| Cabuzu, D; Cirja, A; Grumezescu, AM; Puiu, R | 1 |
| Li, CL; Liu, YW; Qiu, Y; Sun, HP; Sun, XY; Tang, DQ; Yin, XX; Yu, YY; Zhang, L | 1 |
| Kang, MK; Lee, J; Nguyen, AH; Sim, SJ | 1 |
| Wang, C; Wang, Z | 1 |
| Shen, Y | 1 |
| Hao, Y; Liu, L; Xu, M; Zhou, Y | 1 |
| Che, X; Feng, XH; Huang, XF; Meng, DL; Shang, L | 1 |
| Huang, N; Jiang, M; Liu, L; Xia, N; Zhang, J; Zhou, B | 1 |
| Akkari, L; Barcikowski, S; Bormann, J; Decker, C; Korth, C; Müller-Schiffmann, A; Nagel-Steger, L; Niemeyer, FC; Rehbock, C; Sacca, B; Schrader, T; Streich, C; Willbold, D | 1 |
| Liu, J; Sun, J; Xie, W; Yang, L; Yin, T | 1 |
| Di Lorenzo, M; Moreira, FTC; Sale, MGF | 1 |
| Liu, J; Liu, Y; Sun, J; Yang, L; Yin, T; Zhou, Y | 1 |
| Cicchi, S; Fedeli, S; Lisi, S; Minunni, M; Pascale, E; Peyrin, E; Ravelet, C; Scarano, S | 1 |
| Delkhahi, S; Rahaie, M; Rahimi, F | 1 |
| Alsaiari, S; Julfakyan, K; Khashab, NM; Martins, PA; Nie, Z | 1 |
| Dong, X; Sun, Y; Xiong, N; Zhao, Y; Zheng, J | 1 |
| Chen, R; Gao, G; Gong, D; Hu, X; Sun, T; Zhang, M | 1 |
| Galla, HJ; Hüwel, S; Kogan, MJ; Ruff, J; Simon, U | 1 |
| Arbneshi, T; Kalluri, JR; Neely, A; Perry, C; Ray, PC; Senapati, D; Singh, AK; Varisli, B | 1 |
| Geng, J; Qu, K; Qu, X; Ren, J | 1 |
| Andrieux, K; Brambilla, D; Couvreur, P; Hashemi, SH; Le Droumaguet, B; Moghimi, SM; Nicolas, J; Wu, LP | 1 |
| Guo, K; Kraatz, HB; Li, X | 1 |
| Kraziński, BE; Radecka, H; Radecki, J | 1 |
| Dey, A; Dey, SG; Mukherjee, S; Pramanik, D; Sengupta, K | 1 |
| Araya, E; Egea, G; Giralt, E; Guerrero, S; Kogan, MJ; López-Iglesias, C; Molina, C; Prades, R; Salas, E; Selva, J; Teixidó, M; Zurita, E | 1 |
| Liu, D; Wang, C; Wang, Z | 1 |
| Chang, YC; Chang, YJ; Chen, YR; Liao, YH; Yoshiike, Y | 1 |
| Chen, W; He, S; Jiang, X; Liu, D; Sun, J; Tian, Y; Wang, Z; Zheng, W | 1 |
| Bautista, MR; Inbar, P; Takayama, SA; Yang, J | 1 |
| Le Quesne, PM | 1 |
| Attanasio, A; Giordana, MT; Migheli, A | 1 |
| Marumo, F | 1 |
| Bancher, C; Budka, H; Grundke-Iqbal, I; Iqbal, K; Lassmann, H; Seitelberger, F; Wiche, G; Wisniewski, HM | 1 |
| Avila, J; Montejo de Garcini, E | 1 |
10 review(s) available for gold and Alzheimer Disease
| Article | Year |
|---|---|
Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier.
Topics: Alzheimer Disease; Blood-Brain Barrier; Brain; Brain Neoplasms; Drug Delivery Systems; Endothelial Cells; Gold; Humans; Metal Nanoparticles; Nanoparticles | 2022 |
Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Drug Delivery Systems; Gold; Humans; Metal Nanoparticles; Nanoparticles | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents; Cytokines; Gold; Humans; Metal Nanoparticles; Neurodegenerative Diseases | 2023 |
Anti-Amyloid Aggregating Gold Nanoparticles: Can they Really be Translated from Bench to Bedside for Alzheimer's Disease Treatment?
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Biomarkers; Blood-Brain Barrier; Brain; Catechin; Gene Expression Regulation; Gold; Humans; Metal Nanoparticles; Molecular Targeted Therapy; Neuroprotective Agents; Protein Aggregates; Resveratrol; Translational Research, Biomedical | 2020 |
Anti-Aβ drug candidates in clinical trials and plasmonic nanoparticle-based drug-screen for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Drug Evaluation; Gold; Humans; Metal Nanoparticles; Plaque, Amyloid | 2018 |
Impact of nanoparticles on amyloid peptide and protein aggregation: a review with a focus on gold nanoparticles.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Gold; Humans; Metal Nanoparticles; Molecular Dynamics Simulation; Protein Aggregates; Surface Properties | 2018 |
Biomedical applications of gold nanoparticles.
Topics: Alzheimer Disease; Amyloid; Animals; Diagnostic Imaging; Gold; Humans; Metal Nanoparticles; Neoplasms; Particle Size; Theranostic Nanomedicine | 2015 |
Detection of Aβ Monomers and Oligomers: Early Diagnosis of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biosensing Techniques; Colorimetry; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Fluorescent Dyes; Gold; Humans; Metal Nanoparticles; Surface Plasmon Resonance | 2016 |
Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.
Topics: Acridines; Alzheimer Disease; Amyloid beta-Peptides; Benzothiazoles; Biocompatible Materials; Biomarkers; Brain; Chromones; Drug Delivery Systems; Ferric Compounds; Gold; Humans; Magnetite Nanoparticles; Nanoparticles; Thiazoles | 2011 |
1 trial(s) available for gold and Alzheimer Disease
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
152 other study(ies) available for gold and Alzheimer Disease
| Article | Year |
|---|---|
Impact of Au
Topics: Alzheimer Disease; Amyloid beta-Peptides; Gold; Humans; Metal Nanoparticles; Peptide Fragments; Thermodynamics | 2022 |
Self-Assembly of Superquenched Gold Nanoparticle Nanosensors for Lighting up BACE-1 in Live Cells.
Topics: Alzheimer Disease; DNA; Fluorescent Dyes; Gold; Humans; Metal Nanoparticles | 2021 |
Ultrasensitive Detection of Alzheimer's Amyloids on a Plasmonic-Gold Platform.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomimetic Materials; Gold; Humans; Immunoassay; Materials Testing; Metal Nanoparticles; Particle Size | 2021 |
Controllable signal molecule release from Au NP-gated MSNs for photocathodic detection of ultralow level AβO.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Copper; Electrochemical Techniques; Electrodes; Gold; Humans; Light; Limit of Detection; Metal Nanoparticles; Nanostructures; Phenothiazines; Quantum Dots; Reproducibility of Results; Silicon Dioxide | 2022 |
Evaluating effect of metallic ions on aggregation behavior of β-amyloid peptides by atomic force microscope and surface-enhanced Raman Scattering.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Gold; Humans; Ions; Peptide Fragments; Spectrum Analysis, Raman | 2021 |
Gold Nanorods with Spatial Separation of CeO
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Biocompatible Materials; Blood-Brain Barrier; Cerium; Gold; Humans; Materials Testing; Nanotubes; Photothermal Therapy | 2022 |
An Electrochemiluminescence Biosensor for the Detection of Alzheimer's Tau Protein Based on Gold Nanostar Decorated Carbon Nitride Nanosheets.
Topics: Alzheimer Disease; Area Under Curve; Biosensing Techniques; Gold; Humans; Limit of Detection; Luminescent Measurements; Microscopy, Electron, Scanning; Nanostructures; Nitriles; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; tau Proteins | 2022 |
Comparative study of biogenically synthesized silver and gold nanoparticles of Acacia auriculiformis leaves and their efficacy against Alzheimer's and Parkinson's disease.
Topics: Acacia; Alzheimer Disease; Anti-Bacterial Agents; Gold; Metal Nanoparticles; Parkinson Disease; Plant Extracts; Plant Leaves; Silver; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2022 |
Development of a biosensor for phosphorylated Tau 181 protein detection in Early-Stage Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Humans; Immunoassay; Limit of Detection; Metal Nanoparticles; Nanotubes, Carbon; Platinum; Reproducibility of Results | 2022 |
Anti-Amyloidogenic and Fibril-Disaggregating Potency of the Levodopa-Functionalized Gold Nanoroses as Exemplified in a Diphenylalanine-Based Amyloid Model.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Gold; Humans; Levodopa; Peptide Fragments; Phenylalanine | 2022 |
Gold nanourchin enhances detection of Alzheimer's disease biomarker "miRNA-137" on dual electrode sensing surface.
Topics: Alzheimer Disease; Biomarkers; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Humans; Limit of Detection; Metal Nanoparticles; MicroRNAs | 2022 |
Composite of gold nanoclusters and basified human serum albumin significantly boosts the inhibition of Alzheimer's β-amyloid by photo-oxygenation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Gold; Humans; Oxidants; Serum Albumin, Human | 2022 |
Development of amyloid beta gold nanorod aggregates as optoacoustic probes.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Gold; Nanotubes | 2022 |
Surface enhanced fluorescence effect improves the in vivo detection of amyloid aggregates.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Fluorescent Dyes; Gold; Metal Nanoparticles; Mice | 2022 |
GSH-AuNP anti-oxidative stress, ER stress and mitochondrial dysfunction in amyloid-beta peptide-treated human neural stem cells.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Endoplasmic Reticulum Stress; Glutathione; Gold; Humans; Metal Nanoparticles; Mitochondria; Neural Stem Cells; NF-E2-Related Factor 2; Oxidative Stress; Superoxide Dismutase | 2022 |
Portable Vertical Graphene@Au-Based Electrochemical Aptasensing Platform for Point-of-Care Testing of Tau Protein in the Blood.
Topics: Alzheimer Disease; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Graphite; Humans; Limit of Detection; Neurodegenerative Diseases; Point-of-Care Testing; tau Proteins | 2022 |
Ultrasensitive detection of multiple Alzheimer's disease biomarkers by SERS-LFA.
Topics: Alzheimer Disease; Biomarkers; Gold; Humans; Metal Nanoparticles; Spectrum Analysis, Raman | 2022 |
Inhibition of Alzheimer's Aβ
Topics: Alzheimer Disease; Amyloid beta-Peptides; Copper; Gold; Humans; Ions; Metal Nanoparticles; Neuroblastoma; Peptide Fragments | 2022 |
Sensitivity enhancement of magneto-optical Faraday effect immunoassay method based on biofunctionalized γ-Fe
Topics: Alzheimer Disease; Ferric Compounds; Gold; Humans; Immunoassay; Metal Nanoparticles; Nanoparticles; tau Proteins | 2022 |
Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Dendrimers; Gold; Humans; Neurons; Neuroprotective Agents | 2022 |
Aptamer conjugated polydopamine-coated gold nanoparticles as a dual-action nanoplatform targeting β-amyloid peptide for Alzheimer's disease therapy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Gold; Humans; Metal Nanoparticles | 2022 |
Earlier Detection of Alzheimer's Disease Based on a Novel Biomarker
Topics: Alzheimer Disease; Antibodies, Monoclonal; Biomarkers; Biosensing Techniques; Delivery of Health Care; Early Diagnosis; Electrochemical Techniques; Electrodes; Gold; Humans; Immunoassay; Limit of Detection; tau Proteins | 2022 |
Printed Electrochemical Strip for the Detection of miRNA-29a: A Possible Biomarker Related to Alzheimer's Disease.
Topics: Alzheimer Disease; Biomarkers; Biosensing Techniques; Gold; Humans; Metal Nanoparticles; MicroRNAs; Neurodegenerative Diseases | 2022 |
Electrochemical Immunosensor for Early Detection of β-Amyloid Alzheimer's Disease Biomarker Based on Aligned Carbon Nanotubes Gold Nanocomposites.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Biosensing Techniques; Gold; Humans; Immunoassay; Metal Nanoparticles; Nanocomposites; Nanotubes, Carbon | 2022 |
Multifunctional Architectures of Cyclic Dipeptide Copolymers and Composites, and Modulation of Multifaceted Amyloid-β Toxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Dipeptides; Gold; Humans; Metal Nanoparticles; Peptide Fragments | 2022 |
Functionalised penetrating peptide-chondroitin sulphate‑gold nanoparticles: Synthesis, characterization, and applications as an anti-Alzheimer's disease drug.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Chondroitin Sulfates; Gold; Humans; Metal Nanoparticles; Neuroblastoma; Oxidative Stress; Peptide Fragments; Pharmaceutical Preparations | 2023 |
Protective mechanism of gold nanoparticles on human neural stem cells injured by β-amyloid protein through miR-21-5p/SOCS6 pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Gold; Humans; Metal Nanoparticles; MicroRNAs; Neural Stem Cells; Reactive Oxygen Species; Suppressor of Cytokine Signaling Proteins | 2023 |
Zinc-Epigallocatechin-3-gallate Network-Coated Nanocomposites against the Pathogenesis of Amyloid-Beta.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Catechin; Gold; Humans; Metal Nanoparticles; Zinc | 2023 |
Machine Learning-Assisted Nanoenzyme/Bioenzyme Dual-Coupled Array for Rapid Detection of Amyloids.
Topics: Alzheimer Disease; Amyloid; Animals; Gold; Machine Learning; Metal Nanoparticles; Mice | 2023 |
Cytotoxicity, uptake and accumulation of selenium nanoparticles and other selenium species in neuroblastoma cell lines related to Alzheimer's disease by using cytotoxicity assays, TEM and single cell-ICP-MS.
Topics: Alzheimer Disease; Animals; Gold; Humans; Metal Nanoparticles; Mice; Microscopy, Electron, Transmission; Neuroblastoma; Neurodegenerative Diseases; Selenium | 2023 |
BBB-on-a-chip with integrated micro-TEER for permeability evaluation of multi-functionalized gold nanorods against Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Astrocytes; Blood-Brain Barrier; Electric Impedance; Endothelial Cells; Endothelium; Gold; Humans; Lab-On-A-Chip Devices; Permeability | 2023 |
Electrostatic assembly of gold nanoparticle and metal-organic framework nanoparticles attenuates amyloid β aggregate-mediated neurotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Gold; Metal Nanoparticles; Metal-Organic Frameworks; Rats; Static Electricity | 2023 |
A turn-on unlabeled colorimetric biosensor based on aptamer-AuNPs conjugates for amyloid-β oligomer detection.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aptamers, Nucleotide; Biosensing Techniques; Colorimetry; Gold; Humans; Limit of Detection; Metal Nanoparticles | 2023 |
Bifunctional cysteine gold nanoclusters for β-amyloid fibril inhibition and fluorescence imaging: a distinctive approach to manage Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Cysteine; Gold; Molecular Docking Simulation; Plaque, Amyloid; Sulfur | 2023 |
Construction of a microcavity-based microfluidic chip with simultaneous SERS quantification of dual biomarkers for early diagnosis of Alzheimer's disease.
Topics: Alzheimer Disease; Biomarkers; Early Diagnosis; Gold; Humans; Metal Nanoparticles; Microfluidics; Spectrum Analysis, Raman | 2023 |
A tetrahydroacridine derivative and its conjugate with gold nanoparticles: promising agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Gold; Gold Radioisotopes; Humans; Metal Nanoparticles | 2023 |
Construction of Porous Perovskite Oxide Microrods with Au Nanoparticle Anchor for Precise Metabolic Diagnosis of Alzheimer's Disease.
Topics: Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Gold; Humans; Metal Nanoparticles; Oxides; Porosity | 2023 |
Electrochemical magneto-immunoassay for detection of ADAM10 Alzheimer's biomarker using gold nanoparticles as label.
Topics: ADAM10 Protein; Aged; Alzheimer Disease; Amyloid Precursor Protein Secretases; Biomarkers; Gold; Humans; Immunoassay; Membrane Proteins; Metal Nanoparticles | 2024 |
Vertical Graphene-Based Printed Electrochemical Biosensor for Simultaneous Detection of Four Alzheimer's Disease Blood Biomarkers.
Topics: Alzheimer Disease; Biomarkers; Gold; Graphite; Humans; Metal Nanoparticles | 2023 |
Design of an electrochemical aptasensor in the presence of an array of gold nanostructure and a GO-MWCNTs nanocomposite: application in diagnosis of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Gold; Humans; Nanocomposites; Nanotubes, Carbon; Reproducibility of Results | 2023 |
Multilayered Bioorthogonal SERS Nanoprobes Selectively Aggregating in Human Fluids: A Smart Optical Assay for β-Amyloid Peptide Quantification.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Gold; Humans; Metal Nanoparticles | 2023 |
Application of Pt@ZIF-8 nanocomposite-based electrochemical biosensor for sensitive diagnosis of tau protein in Alzheimer's disease patients.
Topics: Alzheimer Disease; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Immunoassay; Limit of Detection; Metal Nanoparticles; Nanocomposites; Platinum; Reproducibility of Results; tau Proteins; Zeolites | 2023 |
Development of a P-tau217 Electrochemiluminescent Immunosensor Reinforced with Au-Cu Nanoparticles for Alzheimer's Disease Precaution.
Topics: Alzheimer Disease; Antibodies; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Immunoassay; Luminescent Measurements; Luminol; Metal Nanoparticles; Nanoparticles; Reproducibility of Results | 2023 |
Chiral nanoparticle-remodeled gut microbiota alleviates neurodegeneration via the gut-brain axis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain-Gut Axis; Gastrointestinal Microbiome; Gold; Humans; Metal Nanoparticles; Mice; Neuroinflammatory Diseases | 2023 |
Lithography-free interdigitated electrodes by trench-filling patterning on polymer substrate for Alzheimer's disease detection.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biosensing Techniques; Electrodes; Gold; Humans; Microelectrodes; Reproducibility of Results | 2024 |
Self-calibrating surface-enhanced Raman scattering-lateral flow immunoassay for determination of amyloid-β biomarker of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Biosensing Techniques; Gold; Humans; Immunoassay; Metal Nanoparticles; Spectrum Analysis, Raman | 2024 |
Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Blood-Brain Barrier; Caseins; Chelating Agents; Cognition; Disease Models, Animal; Drug Carriers; Embryo, Nonmammalian; Female; Gold; High-Throughput Screening Assays; Humans; Male; Metal Nanoparticles; Peptide Fragments; Permeability; Treatment Outcome; Zebrafish | 2019 |
Plasmon-Activated Water Reduces Amyloid Burden and Improves Memory in Animals with Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Disease Progression; Gold; Humans; Hydrogen Bonding; Male; Memory Disorders; Metal Nanoparticles; Mice; Mice, Transgenic; Presenilin-1; Surface Plasmon Resonance; Water | 2019 |
Sensitive electrochemical detection of amyloid beta peptide in human serum using an interdigitated chain-shaped electrode.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Humans; Peptide Fragments | 2019 |
Gold Nanoparticles Treatment Reverses Brain Damage in Alzheimer's Disease Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Brain; Brain Injuries; Cognitive Dysfunction; Disease Models, Animal; Gold; Hippocampus; Male; Metal Nanoparticles; Neuroprotective Agents; Rats, Wistar | 2020 |
Colorimetric Paper-Based Immunosensor for Simultaneous Determination of Fetuin B and Clusterin toward Early Alzheimer's Diagnosis.
Topics: Alzheimer Disease; Biosensing Techniques; Clusterin; Colorimetry; Fetuin-B; Gold; Humans; Immunoassay; Metal Nanoparticles; Paper | 2019 |
Competitive electrochemical immunosensor for the detection of unfolded p53 protein in blood as biomarker for Alzheimer's disease.
Topics: Alzheimer Disease; Antibodies; Biomarkers; Biosensing Techniques; Carbon; Electrochemical Techniques; Electrodes; Gold; Humans; Immunoassay; Intrinsically Disordered Proteins; Limit of Detection; Metal Nanoparticles; Protein Isoforms; Reproducibility of Results; Tumor Suppressor Protein p53 | 2020 |
An aptamer based fluorometric assay for amyloid-β oligomers using a metal-organic framework of type Ru@MIL-101(Al) and enzyme-assisted recycling.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aptamers, Nucleotide; Biosensing Techniques; Exonucleases; Fluorometry; Gold; Humans; Limit of Detection; Metal Nanoparticles; Metal-Organic Frameworks; Recycling | 2020 |
Fiber-cap biosensors for SERS analysis of liquid samples.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antibodies, Immobilized; Biomarkers; Biosensing Techniques; Dimethylpolysiloxanes; Gold; Humans; Metal Nanoparticles; Nanostructures; Optical Fibers; Rhodamines; Spectrum Analysis, Raman | 2020 |
Interface engineering of microelectrodes toward ultrasensitive monitoring of β-amyloid peptides in cerebrospinal fluid in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cations, Divalent; Copper; Electrochemical Techniques; Gold; Hemin; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Microelectrodes | 2020 |
The Clustering of mApoE Anti-Amyloidogenic Peptide on Nanoparticle Surface Does Not Alter Its Performance in Controlling Beta-Amyloid Aggregation.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Apolipoproteins E; Brain; Cluster Analysis; Gold; Humans; Metal Nanoparticles; Peptide Fragments; Plaque, Amyloid; Protein Binding | 2020 |
Unraveling the complexity of amyloid polymorphism using gold nanoparticles and cryo-EM.
Topics: Alzheimer Disease; Amyloid; Brain; Cryoelectron Microscopy; Gold; Humans; Immunoglobulin Light-chain Amyloidosis; Metal Nanoparticles; Neurofibrillary Tangles; Polymorphism, Genetic | 2020 |
Carboxylic Acid-Functionalized, Graphitic Layer-Coated Three-Dimensional SERS Substrate for Label-Free Analysis of Alzheimer's Disease Biomarkers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Carboxylic Acids; Equipment Design; Gold; Graphite; Humans; Nanostructures; Nanowires; Spectrum Analysis, Raman; tau Proteins | 2020 |
Nanogold Neuroprotection in Human Neural Stem Cells Against Amyloid-beta-induced Mitochondrial Dysfunction.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Gold; Humans; Metal Nanoparticles; Mitochondria; Neural Stem Cells; Neuroprotection; Neuroprotective Agents | 2020 |
Bifunctional Au@Pt/Au core@shell Nanoparticles As Novel Electrocatalytic Tags in Immunosensing: Application for Alzheimer's Disease Biomarker Detection.
Topics: Alzheimer Disease; Biomarkers; Biosensing Techniques; Catalysis; Electrochemical Techniques; Gold; Immunoassay; Metal Nanoparticles; Platinum; Tumor Suppressor Protein p53 | 2020 |
DNAzyme-Powered Three-Dimensional DNA Walker Nanoprobe for Detection Amyloid β-Peptide Oligomer in Living Cells and in Vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cell Line; Disease Models, Animal; DNA; DNA, Catalytic; Fluorescent Dyes; Gold; Limit of Detection; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Optical Imaging; Rhodamines; Zinc | 2020 |
An electrochemical immunosensor using gold nanoparticles-PAMAM-nanostructured screen-printed carbon electrodes for tau protein determination in plasma and brain tissues from Alzheimer patients.
Topics: Alzheimer Disease; Biosensing Techniques; Brain; Carbon; Electrochemical Techniques; Electrodes; Gold; Humans; Hydrogen Peroxide; Immunoassay; Limit of Detection; Metal Nanoparticles; tau Proteins | 2020 |
Hollow core photonic crystal fiber-assisted Raman spectroscopy as a tool for the detection of Alzheimer's disease biomarkers.
Topics: Alzheimer Disease; Biomarkers; Gold; Humans; Photons; Spectrum Analysis, Raman | 2020 |
Electrochemical dual-aptamer biosensors based on nanostructured multielectrode arrays for the detection of neuronal biomarkers.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Aptamers, Nucleotide; Biomarkers; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Limit of Detection; Microelectrodes; Nanostructures | 2020 |
Analysis of Tau-441 protein in clinical samples using rGO/AuNP nanocomposite-supported disposable impedimetric neuro-biosensing platform: Towards Alzheimer's disease detection.
Topics: Alzheimer Disease; Biosensing Techniques; Electrodes; Gold; Graphite; Humans; Immunoassay; Metal Nanoparticles; Nanocomposites; tau Proteins | 2020 |
Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Brain; Cell Survival; Disease Models, Animal; Gold; Male; Memory Disorders; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Peptide Fragments; Stereoisomerism | 2020 |
Multiplex monitoring of Alzheimer associated miRNAs based on the modular logic circuit operation and doping of catalytic hairpin assembly.
Topics: Alzheimer Disease; Biosensing Techniques; Gold; Humans; Metal Nanoparticles; MicroRNAs | 2020 |
Fluorescence switch of gold nanoclusters stabilized with bovine serum albumin for efficient and sensitive detection of cysteine and copper ion in mice with Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Copper; Cysteine; Fluorescence; Gold; Metal Nanoparticles; Mice; Serum Albumin, Bovine; Spectrometry, Fluorescence | 2021 |
Isomeric Effect of Nano-Inhibitors on Aβ
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Benzoates; Gold; Humans; Isomerism; Metal Nanoparticles; Peptide Fragments; Protein Aggregates; Protein Folding; Salicylates; Sulfhydryl Compounds | 2021 |
Determination of β-amyloid oligomer using electrochemiluminescent aptasensor with signal enhancement by AuNP/MOF nanocomposite.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aptamers, Nucleotide; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Limit of Detection; Luminescent Agents; Luminescent Measurements; Luminol; Metal Nanoparticles; Metal-Organic Frameworks | 2021 |
Neuroprotective effects of maize tetrapeptide-anchored gold nanoparticles in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Disease Models, Animal; Gold; Metal Nanoparticles; Mice; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Zea mays | 2021 |
Quantitative imaging of amyloid beta peptide (Aβ) in Alzheimer's brain tissue by laser ablation ICP-MS using gold nanoparticles as labels.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Gold; Laser Therapy; Metal Nanoparticles; Mice | 2021 |
Specific detection of Staphylococcus aureus infection and marker for Alzheimer disease by surface enhanced Raman spectroscopy using silver and gold nanoparticle-coated magnetic polystyrene beads.
Topics: Alzheimer Disease; Ascorbic Acid; Biomarkers; Dopamine; Gold; Humans; Magnetic Iron Oxide Nanoparticles; Particle Size; Polystyrenes; Silver; Spectrum Analysis, Raman; Staphylococcal Infections; Staphylococcus aureus; Streptavidin; Synovial Fluid; tau Proteins | 2021 |
Alzheimer's Disease Determination by a Dual Probe on Gold Nanourchins and Nanohorn Hybrids.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Electrodes; Gold; Humans; Limit of Detection; Linear Models; Molecular Probes; Nanoparticles; Peptide Fragments; Protein Multimerization; Reproducibility of Results; Spectrometry, X-Ray Emission; Surface Properties | 2021 |
An excellent electrochemical aptasensor for amyloid-β oligomers based on a triple-helix aptamer switch via target-triggered signal transduction DNA displacement events.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aptamers, Nucleotide; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Humans; Metal Nanoparticles | 2021 |
In vivo micro computed tomography detection and decrease in amyloid load by using multifunctionalized gold nanorods: a neurotheranostic platform for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Gold; Mice; Mice, Transgenic; Nanotubes; X-Ray Microtomography | 2021 |
A Multi-Chamber Paper-Based Platform for the Detection of Amyloid β Oligomers 42 via Copper-Enhanced Gold Immunoblotting.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Biosensing Techniques; Copper; Gold; Humans; Immunoblotting; Limit of Detection; Metal Nanoparticles; Peptide Fragments | 2021 |
Effect of gold nanoparticles on the structure and neuroprotective function of protein L-isoaspartyl methyltransferase (PIMT).
Topics: Alzheimer Disease; Animals; Calorimetry; Gold; Humans; Isoaspartic Acid; Metal Nanoparticles; Models, Theoretical; Protein D-Aspartate-L-Isoaspartate Methyltransferase | 2021 |
Chiral Plasmonic Triangular Nanorings with SERS Activity for Ultrasensitive Detection of Amyloid Proteins in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloidogenic Proteins; Gold; Metal Nanoparticles; Silver; Spectrum Analysis, Raman | 2021 |
Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biomarkers; Brain; Cell Line, Tumor; Cognitive Dysfunction; Cysteine Endopeptidases; Disease Models, Animal; Early Diagnosis; Female; Glioblastoma; Glioma; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Amyloid | 2021 |
Deciphering the Biochemical Pathway and Pharmacokinetic Study of Amyloid βeta-42 with Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Using Systems Biology Approach.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Dextrans; Gold; Humans; Magnetite Nanoparticles; Molecular Docking Simulation; Peptide Fragments; Signal Transduction; Systems Biology | 2018 |
Gold nanoparticles prevent cognitive deficits, oxidative stress and inflammation in a rat model of sporadic dementia of Alzheimer's type.
Topics: Alzheimer Disease; Animals; Cognition; Dementia; Gold; Inflammation; Maze Learning; Metal Nanoparticles; Oxidative Stress; Rats | 2017 |
Peptide multifunctionalized gold nanorods decrease toxicity of β-amyloid peptide in a Caenorhabditis elegans model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Gold; Humans; Nanotubes; Oligopeptides; Peptides; Protein Aggregates; Protein Aggregation, Pathological | 2017 |
Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anthocyanins; Drug Delivery Systems; Glycogen Synthase Kinase 3 beta; Gold; Inflammation; MAP Kinase Signaling System; Metal Nanoparticles; Mice; Neuroprotective Agents; NF-kappa B; Peptide Fragments; Polyethylene Glycols; Signal Transduction | 2017 |
Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces.
Topics: Alzheimer Disease; Citric Acid; Colorimetry; Cysteamine; Female; Gold; Humans; Male; Metal Nanoparticles; Multiple Sclerosis; Polyethylene Glycols; Protein Corona; Sensitivity and Specificity; Spectrometry, Fluorescence | 2017 |
Using Multifunctional Peptide Conjugated Au Nanorods for Monitoring β-amyloid Aggregation and Chemo-Photothermal Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid; Animals; Cell Line, Tumor; Cerebrospinal Fluid; Drug Therapy; Gold; Hyperthermia, Induced; Mice; Nanotubes; Peptides; Rats | 2017 |
A shape-code nanoplasmonic biosensor for multiplex detection of Alzheimer's disease biomarkers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Equipment Design; Gold; Humans; Limit of Detection; Metal Nanoparticles; Peptide Fragments; Surface Plasmon Resonance | 2018 |
Electrochemical Detection of Plasma Immunoglobulin as a Biomarker for Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Biomarkers; Blood Chemical Analysis; Electrochemistry; Gold; Humans; Immunoglobulins; Reproducibility of Results | 2017 |
Photonic crystals on copolymer film for label-free detection of DNA hybridization.
Topics: Alzheimer Disease; Apolipoprotein E4; Biosensing Techniques; Gold; Humans; Metal Nanoparticles; Nucleic Acid Hybridization; Photons; Polymorphism, Single Nucleotide; Surface Plasmon Resonance | 2018 |
Light-Up Nonthiolated Aptasensor for Low-Mass, Soluble Amyloid-β
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aptamers, Nucleotide; Biosensing Techniques; Colloids; Gold; Humans; Limit of Detection; Metal Nanoparticles; Peptide Fragments; Protein Multimerization; Sodium Chloride | 2018 |
A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Biosensing Techniques; Dielectric Spectroscopy; Electrodes; Gold; Graphite; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Limit of Detection; Metal Nanoparticles; Prions; Sensitivity and Specificity | 2018 |
Label-free detection of β-amyloid peptides (Aβ40 and Aβ42): a colorimetric sensor array for plasma monitoring of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Colorimetry; Gold; Humans; Metal Nanoparticles; Peptide Fragments; Silver | 2018 |
Exploring the Mechanism of Inhibition of Au Nanoparticles on the Aggregation of Amyloid-β(16-22) Peptides at the Atom Level by All-Atom Molecular Dynamics.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Dose-Response Relationship, Drug; Gold; Humans; Hydrophobic and Hydrophilic Interactions; Metal Nanoparticles; Molecular Dynamics Simulation; Protein Aggregation, Pathological; Water | 2018 |
A novel electrochemical aptamer-antibody sandwich assay for the detection of tau-381 in human serum.
Topics: Alzheimer Disease; Antibodies; Aptamers, Nucleotide; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Humans; Limit of Detection; Metal Nanoparticles; Reproducibility of Results; tau Proteins | 2018 |
A gold nanocluster chemical tongue sensor array for Alzheimer's disease diagnosis.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Biosensing Techniques; Blood Proteins; Case-Control Studies; Diagnosis, Differential; Fatty Acids; Female; Fluorescence; Gold; Humans; Male; Metal Nanoparticles; Middle Aged; Osteoarthritis; Protein Array Analysis; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2019 |
Voltammetric determination of the Alzheimer's disease-related ApoE 4 gene from unamplified genomic DNA extracts by ferrocene-capped gold nanoparticles.
Topics: Alzheimer Disease; Apolipoprotein E4; Biosensing Techniques; DNA; Electrochemical Techniques; Ferrous Compounds; Gold; Humans; Limit of Detection; Metal Nanoparticles; Metallocenes | 2018 |
Modernization of Golgi staining techniques for high-resolution, 3-dimensional imaging of individual neurons.
Topics: Alzheimer Disease; Animals; Brain; Gold; Imaging, Three-Dimensional; Mice; Microscopy, Electron, Scanning; Neurons; Single-Cell Analysis; Staining and Labeling | 2019 |
A photoelectrochemical sandwich immunoassay for protein S100β, a biomarker for Alzheimer's disease, using an ITO electrode modified with a reduced graphene oxide-gold conjugate and CdS-labeled secondary antibody.
Topics: Alzheimer Disease; Antibodies, Immobilized; Biomarkers; Cadmium Compounds; Electrochemistry; Electrodes; Gold; Graphite; Immunoassay; Models, Molecular; Molecular Conformation; Oxidation-Reduction; Oxides; Photochemical Processes; S100 Calcium Binding Protein beta Subunit; Sulfides; Tin Compounds | 2019 |
Golden Exosomes Selectively Target Brain Pathologies in Neurodegenerative and Neurodevelopmental Disorders.
Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Exosomes; Gold; Mesenchymal Stem Cells; Metal Nanoparticles; Neurodegenerative Diseases; Neurodevelopmental Disorders; Neuroimaging; Tomography, X-Ray Computed | 2019 |
An ultrasensitive electrochemical aptasensor for early diagnosis of Alzheimer's disease, using a fern leaves-like gold nanostructure.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aptamers, Nucleotide; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Metal Nanoparticles | 2019 |
Impact of Gold Nanoparticles on Amyloid β-Induced Alzheimer's Disease in a Rat Animal Model: Involvement of STIM Proteins.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Gold; Hippocampus; Male; Maze Learning; Memory; Metal Nanoparticles; Mice; Phosphorylation; Rats; Rats, Wistar; Stromal Interaction Molecule 1; Stromal Interaction Molecule 2 | 2019 |
Brain targeting of resveratrol through intranasal lipid vesicles labelled with gold nanoparticles:
Topics: Administration, Intranasal; Alzheimer Disease; Animals; Bioaccumulation; Brain; Gold; Lipids; Male; Metal Nanoparticles; Neuroprotective Agents; Particle Size; Rats; Rats, Wistar; Resveratrol; Tomography, X-Ray Computed | 2019 |
Using near-infrared enhanced thermozyme and
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Cell Line, Tumor; Enzyme Stability; Gold; Humans; Hyperthermia, Induced; Infrared Rays; Nanoconjugates; Nanotubes; Peptide Hydrolases; Phototherapy; Proteolysis; Single-Chain Antibodies; Smart Materials; Theranostic Nanomedicine | 2019 |
Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Autophagy; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Gold; Humans; Metal Nanoparticles; Palladium; Particle Size; Quercetin; Structure-Activity Relationship; Surface Properties | 2019 |
Development of a Label-Free Electrochemical Aptasensor for the Detection of Tau381 and its Preliminary Application in AD and Non-AD Patients' Sera.
Topics: Alzheimer Disease; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Graphite; Humans; Limit of Detection; Metal Nanoparticles; Mutant Proteins; Reproducibility of Results; SELEX Aptamer Technique; tau Proteins; Tauopathies | 2019 |
Robust and Universal SERS Sensing Platform for Multiplexed Detection of Alzheimer's Disease Core Biomarkers Using PAapt-AuNPs Conjugates.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aptamers, Nucleotide; Biomarkers; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Metal Nanoparticles; Peptide Fragments; Poly A; Spectrum Analysis, Raman | 2019 |
Ultrasensitive Detection of Amyloid-β Using Cellular Prion Protein on the Highly Conductive Au Nanoparticles-Poly(3,4-ethylene dioxythiophene)-Poly(thiophene-3-acetic acid) Composite Electrode.
Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Animals; Biosensing Techniques; Bridged Bicyclo Compounds, Heterocyclic; Electric Conductivity; Electrochemical Techniques; Electrodes; Gold; Metal Nanoparticles; Mice; Polymers; Prion Proteins; Thiophenes | 2019 |
Electrochemical detection of β-amyloid peptides on electrode covered with N-terminus-specific antibody based on electrocatalytic O2 reduction by Aβ(1-16)-heme-modified gold nanoparticles.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antibodies, Immobilized; Biosensing Techniques; Electrochemical Techniques; Gold; Heme; Humans; Limit of Detection; Nanoparticles; Oxidation-Reduction; Oxygen; Peptide Fragments | 2013 |
Amplified voltammetric characterization of cleavage of the biotinylated peptide by BACE1 and screening of BACE1 inhibitors.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Biosensing Techniques; Biotinylation; Drug Evaluation, Preclinical; Electrochemical Techniques; Enzyme Assays; Gold; Humans; Molecular Sequence Data; Nanoparticles; Peptides | 2013 |
A carbon nanotube metal semiconductor field effect transistor-based biosensor for detection of amyloid-beta in human serum.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Bacterial Outer Membrane Proteins; Biosensing Techniques; Equipment Design; Escherichia coli; Escherichia coli Proteins; Gold; Humans; Limit of Detection; Nanotubes, Carbon; Semiconductors | 2013 |
Gold nanoparticles as amyloid-like fibrillogenesis inhibitors.
Topics: Alzheimer Disease; Amyloid; Animals; Blood-Brain Barrier; Cattle; Circular Dichroism; Drug Delivery Systems; Gold; Humans; Insulin; Metal Nanoparticles; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Protein Multimerization | 2013 |
Long-term effects of aluminium dust inhalation.
Topics: Administration, Inhalation; Aluminum; Alzheimer Disease; Cardiovascular Diseases; Cerebrovascular Disorders; Dust; Follow-Up Studies; Gold; Humans; Male; Mining; Pneumoconiosis; Protective Agents; Silicosis; Western Australia | 2013 |
Noninvasive label-free nanoplasmonic optical imaging for real-time monitoring of in vitro amyloid fibrogenesis.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Brain; Gold; Humans; Metal Nanoparticles; Peptide Fragments; Spectroscopy, Near-Infrared; Surface Plasmon Resonance | 2014 |
Gold nanoparticle-based immuno-PCR for detection of tau protein in cerebrospinal fluid.
Topics: Alzheimer Disease; Antibodies, Monoclonal; Biomarkers; Enzyme-Linked Immunosorbent Assay; Gold; Humans; Metal Nanoparticles; Polymerase Chain Reaction; Sensitivity and Specificity; tau Proteins; Tyramine | 2014 |
Characterization of the enhanced peroxidatic activity of amyloid β peptide-hemin complexes towards neurotransmitters.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensins; Benzidines; Biosensing Techniques; Cytochromes c; Dopamine; Electrochemistry; Electrodes; Gold; Heme; Hemin; Humans; Neurotransmitter Agents; Oxidation-Reduction; Peroxidases; Protein Binding; Serotonin; Surface Properties | 2014 |
Detection of amyloid-β42 using a waveguide-coupled bimetallic surface plasmon resonance sensor chip in the intensity measurement mode.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antibodies, Immobilized; Gold; Peptide Fragments; Silver; Surface Plasmon Resonance | 2014 |
Alzheimer's disease biomarkers detection in human samples by efficient capturing through porous magnetic microspheres and labelling with electrocatalytic gold nanoparticles.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Biomarkers; Catalysis; Conductometry; Gold; Humans; Immunomagnetic Separation; Metal Nanoparticles; Microspheres; Porosity; Reproducibility of Results; Sensitivity and Specificity; Staining and Labeling | 2015 |
Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Drug Carriers; Gold; Humans; Metal Nanoparticles; Molecular Sequence Data; Peptides; Protein Aggregation, Pathological; Tungsten Compounds | 2015 |
Gelsolin bound β-amyloid peptides(1-40/1-42): electrochemical evaluation of levels of soluble peptide associated with Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biosensing Techniques; Gelsolin; Gold; Humans; Hydrogen Peroxide; Limit of Detection; Metal Nanoparticles; Rats | 2015 |
Simple Colorimetric Detection of Amyloid β-peptide (1-40) based on Aggregation of Gold Nanoparticles in the Presence of Copper Ions.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Biosensing Techniques; Cations, Divalent; Colorimetry; Copper; Gold; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Peptide Fragments; Spectrophotometry | 2015 |
A sensitive colorimetric strategy for monitoring cerebral β-amyloid peptides in AD based on dual-functionalized gold nanoplasmonic particles.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Colorimetry; Gold; Metal Nanoparticles; Molecular Structure; Particle Size; Rats; Surface Properties | 2015 |
Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Gold; Humans; Limit of Detection; Metal Nanoparticles; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Surface Plasmon Resonance | 2015 |
Studying the relationship between cell cycle and Alzheimer's disease by gold nanoparticle probes.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antimetabolites; Biomarkers; Biotinylation; Cell Line, Tumor; Down-Regulation; G1 Phase; G2 Phase; Gold; Humans; Immobilized Proteins; Metal Nanoparticles; Molecular Probes; Nerve Tissue Proteins; Neurons; Peptide Fragments; Streptavidin; Surface Properties; Tubulin Modulators; Up-Regulation | 2015 |
Special issue of ChinaNanomedicine 2015.
Topics: Alzheimer Disease; Bacterial Infections; Biomimetic Materials; Capsid; China; Drug Delivery Systems; Gold; Humans; Nanomedicine; Nanoshells; Nanostructures; Neoplasms | 2016 |
Xanthoceraside hollow gold nanoparticles, green pharmaceutics preparation for poorly water-soluble natural anti-AD medicine.
Topics: Alzheimer Disease; Calorimetry, Differential Scanning; Drug Carriers; Gold; Metal Nanoparticles; Microscopy, Electron, Scanning; Pharmaceutical Preparations; Saponins; Silicon Dioxide; Solubility; Technology, Pharmaceutical; Triterpenes; Water; X-Ray Diffraction | 2016 |
Visual and fluorescent assays for selective detection of beta-amyloid oligomers based on the inner filter effect of gold nanoparticles on the fluorescence of CdTe quantum dots.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biosensing Techniques; Cadmium Compounds; Fluorescence; Fluorescent Dyes; Gold; Humans; Limit of Detection; Metal Nanoparticles; Peptide Fragments; Quantum Dots; Solubility; Spectrometry, Fluorescence; Tellurium | 2016 |
Characterizing the Effect of Multivalent Conjugates Composed of Aβ-Specific Ligands and Metal Nanoparticles on Neurotoxic Fibrillar Aggregation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Gold; Ligands; Metal Nanoparticles; Peptide Fragments | 2016 |
Penetratin Peptide-Functionalized Gold Nanostars: Enhanced BBB Permeability and NIR Photothermal Treatment of Alzheimer's Disease Using Ultralow Irradiance.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Carrier Proteins; Cell Line; Cell-Penetrating Peptides; Gold; Humans; Infrared Rays; Mice; Mice, Nude; Nanoparticles; Peptides; Permeability; Phototherapy | 2016 |
Towards timely Alzheimer diagnosis: A self-powered amperometric biosensor for the neurotransmitter acetylcholine.
Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Bioelectric Energy Sources; Biomarkers; Biosensing Techniques; Electrochemical Techniques; Electrodes; Enzymes, Immobilized; Equipment Design; Gold; Humans; Platinum; Point-of-Care Systems; Porosity | 2017 |
Gold nanoparticle-capped mesoporous silica-based H
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Cell Death; Cell Membrane; Cell Shape; Chelating Agents; Copper; Cytoskeleton; Delayed-Action Preparations; Drug Liberation; Fluorescent Antibody Technique; Gold; Hydrogen Peroxide; Metal Nanoparticles; Mice; Neurotoxins; PC12 Cells; Porosity; Rats; Rhodamines; Silicon Dioxide; Tubulin; X-Ray Diffraction | 2016 |
Toward sensitive immuno-based detection of tau protein by surface plasmon resonance coupled to carbon nanostructures as signal amplifiers.
Topics: Alzheimer Disease; Amplifiers, Electronic; Antibodies; Biosensing Techniques; Gold; Humans; Limit of Detection; Nanostructures; Nanotubes, Carbon; Surface Plasmon Resonance; tau Proteins | 2017 |
Design and Fabrication a Gold Nanoparticle-DNA Based Nanobiosensor for Detection of microRNA Involved in Alzheimer's Disease.
Topics: Alzheimer Disease; Biosensing Techniques; Gold; Humans; Limit of Detection; Metal Nanoparticles; MicroRNAs | 2017 |
Self-assembled lipoprotein based gold nanoparticles for detection and photothermal disaggregation of β-amyloid aggregates.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Curcumin; Fluorescent Dyes; Gold; Humans; Infrared Rays; Light; Lipoproteins; Nanoparticles; Peptide Fragments; Protein Aggregates; Spectrometry, Fluorescence; Temperature | 2017 |
Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid β-Protein Aggregation and Cytotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Gold; Humans; Metal Nanoparticles; Peptide Fragments; Protein Structure, Secondary | 2017 |
The size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-β fibrillation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Gold; Humans; Metal Nanoparticles; Peptide Fragments; Protein Aggregation, Pathological | 2017 |
The effects of gold nanoparticles functionalized with ß-amyloid specific peptides on an in vitro model of blood-brain barrier.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biological Transport; Blood-Brain Barrier; Gold; Humans; Metal Nanoparticles; Peptides; Protein Binding | 2017 |
Ultrasensitive and highly selective detection of Alzheimer's disease biomarker using two-photon Rayleigh scattering properties of gold nanoparticle.
Topics: Alzheimer Disease; Antibodies, Monoclonal; Biomarkers; Colorimetry; Gold; Linear Models; Metal Nanoparticles; Photons; Scattering, Radiation; tau Proteins | 2009 |
Rapid and efficient screening of Alzheimer's disease β-amyloid inhibitors using label-free gold nanoparticles.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Protein Precursor; Drug Evaluation, Preclinical; Gold; Ligands; Light; Metal Nanoparticles; Molecular Sequence Data; Scattering, Radiation; Spectrophotometry, Ultraviolet; Staining and Labeling | 2010 |
Exploiting the interactions of PNA-DNA films with Ni2+ ions: detection of nucleobase mismatches and electrochemical genotyping of the single-nucleotide mismatch in apoE 4 related to Alzheimer's disease.
Topics: Alzheimer Disease; Apolipoprotein E4; Base Pair Mismatch; Dielectric Spectroscopy; DNA; DNA Mutational Analysis; Gold; Humans; Nickel; Peptide Nucleic Acids; Polymorphism, Single Nucleotide | 2011 |
Surface plasmon resonance based biosensors for exploring the influence of alkaloids on aggregation of amyloid-β peptide.
Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Biosensing Techniques; Gold; Humans; Surface Plasmon Resonance | 2011 |
Self-assembled monolayers of Aβ peptides on Au electrodes: an artificial platform for probing the reactivity of redox active metals and cofactors relevant to Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Chelating Agents; Copper; Electrodes; Gold; Heme; Humans; Hydrogen Peroxide; Molecular Sequence Data; Mutation; Oxidation-Reduction; Oxygen; Surface Properties | 2012 |
Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Brain; Cattle; Coculture Techniques; Colorimetry; Endothelial Cells; Gold; Humans; Male; Metal Nanoparticles; Microcirculation; Nanotechnology; Peptides; Permeability; Rats; Rats, Sprague-Dawley; Receptors, Transferrin; Serum | 2012 |
Gold nanoparticle based dot-blot immunoassay for sensitively detecting Alzheimer's disease related β-amyloid peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line; Gold; Humans; Immunoassay; Metal Nanoparticles; Models, Molecular; Sensitivity and Specificity | 2012 |
Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Cell Survival; Gold; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Neuroblastoma; Tumor Cells, Cultured | 2012 |
A highly sensitive gold-nanoparticle-based assay for acetylcholinesterase in cerebrospinal fluid of transgenic mice with Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Biomarkers; Colorimetry; Gold; Mice; Mice, Transgenic; Nanoparticles; Sensitivity and Specificity | 2012 |
Gold is newest weapon in battle against Alzheimer's.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Gold; Microwaves; Nanostructures | 2006 |
Assay to screen for molecules that associate with Alzheimer's related beta-amyloid fibrils.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Dopamine; Enzyme-Linked Immunosorbent Assay; Fluorescent Dyes; Gold; Humans; Immunoglobulin G; Metal Nanoparticles; Tannins; Tetracyclines | 2008 |
Metal-induced diseases of the nervous system.
Topics: Aluminum; Alzheimer Disease; Animals; Arsenic Poisoning; Bismuth; Gold; Humans; Lead; Lead Poisoning; Manganese Poisoning; Mercury Poisoning; Metals; Methylmercury Compounds; Nervous System Diseases; Organometallic Compounds; Organotin Compounds; Platinum; Thallium | 1982 |
Postembedding staining of brain tissue for ultrastructural visualization of amyloid in Alzheimer's disease.
Topics: Acrylic Resins; Alzheimer Disease; Amyloid; Brain; Gold; Humans; Immunohistochemistry; Staining and Labeling; Tissue Embedding | 1993 |
[Metabolic disorders of trace elements].
Topics: Aluminum; Alzheimer Disease; Cadmium; Cadmium Poisoning; Chromium; Gold; Humans; Mercury; Metallothionein; Protein Binding; Selenium; Trace Elements; Zinc | 1991 |
Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Antibodies, Monoclonal; Epitopes; Female; Gold; Histocytochemistry; Humans; Immunologic Techniques; Intermediate Filament Proteins; Male; Microscopy, Electron; Microtubule-Associated Proteins; Middle Aged; Neurofibrils; Neurofilament Proteins; Supranuclear Palsy, Progressive; tau Proteins | 1987 |
In vitro conditions for the self-polymerization of the microtubule-associated protein, tau factor.
Topics: Alzheimer Disease; Animals; Glutaminase; Gold; Humans; Hydrogen-Ion Concentration; Immunologic Tests; Microscopy, Electron; Microtubule-Associated Proteins; Nerve Tissue Proteins; Polymers; Protein Conformation; Staphylococcal Protein A; Swine; tau Proteins; Urea | 1987 |